Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


OTC M&A Trend May Be Result Of Too Many Large Players At The Top – Panel

This article was originally published in The Tan Sheet

Executive Summary

A lack of competitive global scale may be one factor fueling the divestiture of OTC units by larger pharma companies

You may also be interested in...

Bristol Consumer Unit Suitors Tasked With Determining Value Of Excedrin

Bristol-Myers Squibb says it will contact potential buyers for its North American Consumer Medicines division "over the coming weeks.

Bayer/Roche Consumer Unit Will Focus On Rx-To-OTC Switch Opportunities

Bayer expects the addition of Roche Consumer Health to bolster the firm's ability to handle future Rx-to-OTC switches

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC


Latest News
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts